Clinical trial · Interventional
The Accuracy of Brain Biological Electrical Impedance Tomography Screen for Supratentorial Tumors
A Prospective, Self-paired, Single-center Clinical Trial Evaluating the Accuracy of Brain Biological Electrical Impedance Tomography Screen for Supratentorial Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Compared with MRI or CT, brain biological electrical impedance tomography were performed on patients with supratentorial tumors and healthy people . The AUC (area under the curve) of ROC, which is associated with the increased maximum and the difference between left and right equilibrium of impedance value, is calculated. The specificity of brain biological electrical impedance tomography in screening supratentorial tumors are evaluated. To compare the changes of parameters detected by brain biological electrical impedance tomography, the enrolled brain tumor patients with cerebral edema were paired with themselves and intravenous infusion of mannitol so that the sensitivity of this device in monitoring cerebral edema can be evaluated.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Edema | — | UNRESOLVED | — |
| Brain Tumor | Brain Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| brain biological electrical impedance tomography | Device | — | UNRESOLVED |
| MRI/CT | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Patients examined with MRI/CT
- interventionNames
- Device: MRI/CT
- type
- OTHER
- label
- Patients examined with biological electrical impedance
- interventionNames
- Device: brain biological electrical impedance tomography
- Device: MRI/CT
Primary outcomes (1)
- measure
- The AUC of ROC curve of the maximum increased value of impedance
- timeFrame
- 1 year
- description
- The AUC of ROC curve of the maximum increased value of impedance
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 ≤70 years old, male or female; 2. Preoperative patients who had been diagnosed with supratentorial tumors by MRI/CT or other conventional methods or healthy people (23 cases each); 3. The longest diameter of the brain tumor is ≥3 cm; 4. Informed Consent Has been signed Exclusion Criteria: 1. Severe systemic compound injury or hemorrhagic shock; 2. Epilepsy, poisoning symptoms; 3. In critical condition; 4. Patients with brain wounds or acute inflammation; 5. Lactation and pregnant women; 6. Those who have no informed consent ability or cannot sign by themselves; 7. The investigator considers it inappropriate for the patient to participate in this clinical trial
References
Publications (0)
Data not yet available